Novo Nordisk A/S (ADR) (NVO)Hedge Funds Are Snapping Up
After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the successful hedge funds and other investment firms that we track...
Posts Tagged ‘NYSE:NVO’
US FDA Approves Sanofi SA (ADR) (SNY) Soliqua 100/33, Novo Nordisk A/S (ADR) (NVO) Xultophy 100/3.6
The US Food and Drug Administration (FDA) has recently approved the Soliqua 100/33 (insulin glargine and lixisenatide injection) of Sanofi SA (ADR) (NYSE:SNY) and the Xultophy...
10 Most Successful Investors in the World
These 10 most successful investors in the world don’t have much in common aside from their obscene net worths.
Novo Nordisk A/S (ADR) (NVO) Revisits New Strategy To Deal With U.S Payers
Novo Nordisk A/S (ADR) (NYSE:NVO) incoming President and CEO Lars Fruergaard Jørgensen is slated to start his leadership roles in the New Year.
Top Performing CEOs in the World and What Top Performing Hedge Funds Think of Their Companies
It is hard to be the CEO of a company these days given the increasing political uncertainty and slow growth being faced by major developed economies.
5 Most Successful Quant Hedge Funds And Their Top Picks
The prominence of quantitative hedge funds in the alternative asset management space has increased exponentially since the turn of the century, with several of them now considered...
Two Dividend Growth Stocks on My Radar
In the past few days, I have noticed that a couple of dividend growth stocks have been selling at lower prices than before.
American Express Company (AXP), Rockwell Collins Inc. (COL) & More: Here’s Why These Stocks Are Trending Today
Markets shrugged off the negative trend and are trading well in the green today amid news that World Trade Organization’s has slashed its world trade forecast to the lowest...
Inside the FDA: Why Sanofi SA (ADR) (SNY) IGlarLixi Was Delayed But Novo Nordisk A/S (ADR) (NVO) IDegLira Wasn’t
Update: Several hours after the initial publication of this report on September 2, Novo Nordisk announced that the FDA has extended the regulatory review for IDeglira, with...
VeriFone (PAY), Gilead (GILD) Among 5 Stocks That Hit 52-Week Lows Last Week
In this article we'll take a look at why VeriFone Systems Inc (NYSE:PAY), Dynavax Technologies Corporation (NASDAQ:DVAX), Gilead Sciences, Inc.
The Cryptic World of Oral Insulin, Novo Nordisk A/S (ADR) (NVO) vs Oramed Pharmaceuticals, Inc. (ORMP)
The problem with being at the top of one of the largest healthcare market niches in the world is extremely heightened expectations.
As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes Drugs
In part I of our comprehensive report on the type II diabetes market, we broke down the top 4 best selling diabetes drugs, their prospects and the companies behind them.
The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All
At the turn of the millennium, the population of the United States clocked in at 282.2 million.
Renaissance Technologies Bullish on PepsiCo (PEP) and Gold Heading Into Q2
Founded in 1982 by James ‘Jim’ Simons, Renaissance Technologies employs quantitative models based on mathematical and statistical analysis to make its stock selections and...
Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds?
Is Novo Nordisk A/S (ADR) (NYSE:NVO) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Multi-Billion-Dollar Fund Renaissance Technologies Entered Q4 With These Top Picks
Well-known hedge fund Renaissance Technologies LLC needs little or no introduction at all.
Arrowstreet Capital Goes Heavily Bullish & Bets Big on These Stocks in Q4
Arrowstreet Capital is a Boston, Massachusetts-based quantitative hedge fund founded by Peter Rathjens, Bruce Clarke and John Campbell in 1999.
Billionaire Ken Fisher’s Top Healthcare Stock Picks
At the beginning of September, when the U.S stock markets were in turmoil, Ken Fisher of Fisher Asset Management asserted that the August correction would be “over just as fast...
New Deal Between Emisphere Technologies Inc. (EMIS) and Novo Nordisk A/S (ADR) (NVO)
On October 15, Emisphere Technologies Inc.
Not Even Jim Simons’ Mathematical Models Could Pick Winning Stocks In Q3
Renaissance Technologies, led by Jim Simons, disclosed a total of 3,196 positions in its latest 13F filing for the reporting period of June 30.
This is What Hedge Funds Have to Say about Two Healthcare Stocks on the Move
Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) are two healthcare companies that recently received product approval in the US and Europe, respectively, but both...
Billionaire Jim Simons’ Top Holdings: Amazon.com Inc. (AMZN), Colgate-Palmolive Company and More
Renaissance Technologies, founded by billionaire Jim Simons, has filed its latest 13F with the U.S.
UnitedHealth Group (UNH), Novo Nordisk (NVO), Johnson & Johnson (JNJ): Cheapest Healthcare Stocks Picked By Markel Gayner
Tom Gayner’s Markel Gayner Asset Management, the investment division of financial holding company Markel Corporation (NYSE:MKL), has filed its latest 13F with the Securities...
Hedge Funds Made A Bundle By Betting On Amazon.com, Inc. (AMZN), Apple, and Pfizer Inc
As we are entering into the second quarter of 2015, it's time to take a brief look back and see how the market performed during the first three months of the year, and most importantly...
Colgate-Palmolive Company (CL), Novo Nordisk A/S (ADR) (NVO) Among Billionaire Jim Simons’ Holdings for Long-Run
The quantitative hedge fund Renaissance Technologies, formerly managed by billionaire Jim Simons, has been so successful that it has been partly responsible for prompting other...
McDonald’s Corporation (MCD), Novo Nordisk A/S (ADR) (NVO), Colgate-Palmolive Company (CL): A Look At Jim Simons’ Top Picks for the Second Quarter
Another major hedge fund that recently disclosed its long equity positions for the second quarter of 2014 is Jim Simons’ Renaissance Technologies, one of the best performing...
Renaissance Technologies Loves These Stocks: McDonald’s Corporation (MCD), Novo Nordisk A/S (ADR) (NVO) & Others
In the latest 13F, Renaissance Technologies, previously managed by Jim Simons, revealed its holding for the fourth quarter of 2013.
Nektar Therapeutics (NKTR), Pfizer Inc. (PFE): What’s MannKind Corporation (MNKD) Really Worth?
This is close to the market cap that Bank of America's Steve Byrne thinks MannKind Corporation (NASDAQ:MNKD) is worth.
Goldman Sachs Group, Inc. (GS), Novo Nordisk A/S (ADR) (NVO), Seaspan Corporation (SSW): Five Stocks Growing Their Dividends by 25% Per Year
Dividend investors would be wise to focus not just on a stock's current yield, but also on the long-term growth potential of its dividends.
MannKind Corporation (MNKD), Seattle Genetics, Inc. (SGEN), Eli Lilly & Co. (LLY): A Pharmacology Primer for Biotech Investors
In pharmacology, we don't only have to consider the actions of the drug on the body.
Express Scripts Holding Company (ESRX), Novo Nordisk A/S (ADR) (NVO), Walgreen Company (WAG): Don’t Mess With This 800-Pound Gorilla in the Pharma Space
Express Scripts Holding Company (NASDAQ:ESRX) -- the largest pharmacy benefit manager, or PBM, in America -- is also one of the most important companies in the health care ...
Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds?
In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to track Mr. Market.
Will This Destroy MannKind Corporation (MNKD)?
The drug more closely mimics how the body secretes insulin after a meal to lower blood sugar, doing its job and leaving the bloodstream quickly.
MannKind Corporation (MNKD): To Infinity And Beyond?
The idea inspired me to issue my own questions about the company, using the questions as a crutch to explain my position.
Allergan, Inc. (AGN): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In the eyes of many of your fellow readers, hedge funds are seen as useless, old financial vehicles of an era lost to time.
Integra Lifesciences Holdings Corp (IART), NuVasive, Inc. (NUVA), CareFusion Corporation (CFN): A Solid Orthopedic Implants Manufacturer
The orthopedic implants market is a growing segment with increasing demand for extremities, spine, and orthobiologics.
Who’s Dumping Teva Pharmaceutical Industries Ltd (ADR) (TEVA)?
Like most pharma companies, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)'s stock price generally trades akin to the actions of a roller coaster.
Novo Nordisk A/S (ADR) (NVO), Dynavax Technologies Corporation (DVAX), Merck & Co., Inc. (MRK): Three Biggest FDA Rejections This Year (So Far)
At least the Food and Drug Administration is polite.
MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co. (LLY): Dreamboat Data? Not Exactly.
MannKind Corporation (NASDAQ:MNKD) ended up more than 10% on Wednesday, after the biotech announced positive results for two phase 3 trials testing its inhaled insulin Afrezza...
MannKind Corporation (MNKD), Eli Lilly & Co. (LLY): The Easiest Prediction in Biotech This Summer
Nothing is for certain in biotech, but it looks to me like the extended phase 3 program has an extremely high likelihood of coming up positive.
Celgene Corporation (CELG), Compugen Ltd. (USA) (CGEN): This Week in Biotech
With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co. (LLY): A Good Drug That’s Too Risky to Buy
In a companion article a few days ago, I predicted that MannKind Corporation (NASDAQ:MNKD)'s extended phase 3 program for its inhaled insulin, Afrezza, is likely to produce ...
Arena Pharmaceuticals, Inc. (ARNA): Nothing to See Here, No Huge Sales Yet
The sales come from less than a month on the market -- the drug launched on June 11 and the quarter closed on June 30 -- and can't tell you anything about the long-term potential...
Novo Nordisk A/S (ADR) (NVO): Three Shocking Numbers on Diabetes’ Grim Future
Diabetes is one of the world's most dangerous and fastest-growing afflictions.
Will Arena Pharmaceuticals, Inc. (ARNA) Earnings Finally Explode Higher?
Arena Pharmaceuticals, Inc.
GlaxoSmithKline plc (ADR) (GSK), Novo Nordisk A/S (ADR) (NVO): China’s Growth Crisis Swings Into High Gear
It's been a long time since China's double-digit economic growth became the envy of nations across the world. Since then, the Chinese economy has slowed.
NutriSystem Inc. (NTRI), Novo Nordisk A/S (ADR) (NVO): Longer But Less Healthy Lives Will Benefit This Trio
NutriSystem Inc. (NASDAQ:NTRI), Novo Nordisk A/S (ADR) (NYSE:NVO), and Universal Health Services, Inc.
The Future of Sanofi SA (ADR) (SNY)’s Insulin Empire
Sanofi SA (ADR) (NYSE:SNY) appeared at the American Diabetes Association meeting last month, touting data for the new insulin U300 and a combo therapy involving its approved drugs...
Could This Safe Play Help Eli Lilly & Co. (LLY)?
At the American Diabetes Association meeting last month, Eli Lilly & Co. (NYSE:LLY) presented promising data for the GLP-1 agonist dulaglutide.
Could This Safe Play Help Eli Lilly & Co. (LLY)?
At the American Diabetes Association meeting last month, Eli Lilly & Co. (NYSE:LLY) presented promising data for the GLP-1 agonist dulaglutide.
